NEW YORK/MILAN/LONDON/HONG KONG (Reuters Breakingviews) - Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.
Stocks pulled back on Friday in a session that was jam-packed with several market-moving topics, including the coronavirus, the President and the monthly jobs report.
In the end though, the major indices managed to post gains for the full week, which hadn’t been done throug
Formula One's Turkish Grand Prix next month will be held without spectators due to the coronavirus outbreak, the Istanbul governor's office said on Monday, as the event returns to Istanbul after an absence of almost a decade.
Markets were up in Asian and early European trade encouraged by the fact that President Trump’s COVID infection appeared to be under control and the US would not need to consider the transfer of power under the 25th Amendment.
New actions to contain the virus are being taken in the US and Europe, but investors are looking past it and taking equities and risk assets, in general, higher to start the new week.
The rouble weakened on Monday, blunted by external risks and rising coronavirus cases in Russia, although higher oil prices and positive updates on the health of U.S. President Donald Trump capped losses.
(RTTNews) - Teva Canada, a unit of Teva Pharmaceutical Industries Ltd. (TEVA), announced Monday the product availability of Aermony RespiClick, a new device for the treatment of bronchial asthma.
(RTTNews) - Accenture Plc (ACN) on Monday announced changes to its Global Management Committee, including the appointment of a new chief strategy officer as well as leadership changes in its U.K. and Ireland business.
Uber Technologies Inc and Lyft Inc together are spending nearly $100 million on a November California ballot initiative to overturn a state law that would compel them to classify drivers as employees.
(RTTNews) - BridgeBio Pharma, Inc. (BBIO), a company focused on genetic diseases,announced Monday a definitive agreement to acquire around 36.3% stake in Eidos Therapeutics, Inc. (EIDX), a company focused on transthyretin or TTR amyloidosis or ATTR, that it does not already own.
Billionaire oil investors Wilks Brothers LLC on Monday raised their hostile offer for Canadian oilfield services provider Calfrac Well Services Ltd to between C$0.18 per share and C$0.25 per share.
SpaceX, the pioneering rocket launch company founded by Elon Musk, famously advertises a launch cost of just $62 million for its Falcon 9 rocket -- a price it has held steady for four and a half years. Of course, for nearly as long, SpaceX has also been saying that a switch to r
I took a look at three stocks to avoid last week, and just one of the three investments declined. Burned by a nearly 42% pop in a home goods retailer, the average pick moved 13.7% higher. The market's 1.5% gain looks tiny in comparison, but I'm going to try again.
Kronos Bio, a Phase 2 biotech developing kinase inhibitor therapies for leukemia and solid tumors, announced terms for its IPO on Monday.
The San Mateo, CA-based company plans to raise $175 million by offering 10.3 million shares at a price range of $16 to $18. At the midpoint of
The Motley Fool got a chance to chat with Melissa Kozak, RN, CRNI, and co-founder and CEO of Citus Health. Here's what she had to share about the future of digital health and how her company is tackling the home healthcare industry.
MILAN (Reuters Breakingviews) - The Italian state has planted its investment flag in another important industry. Local payments group Nexi’s all-share deal to buy state-controlled Sia will create a 15 billion euro domestic champion ready to expand abroad. Sovereign wea
(RTTNews) - Comtech Telecommunications Corp. (CMTL) and Gilat Satellite Networks Ltd. (GILT) announced Monday that the companies have agreed to terminate their
merger agreement, and have settled all pending litigation in the Delaware Court of Chancery.
Checked
24 minutes 57 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article